Evidence map›Paper›PMID 32424027›Full record

ArticleAnnals of the rheumatic diseases2021

Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre

Elizabeth R Graef, Jean W Liew, Alfred Hj Kim, Jeffrey A Sparks

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Response to: 'Correspondence on 'Annals of the rheumatic diseases · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Elizabeth R Graef *Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Jean W Liew *Department of Medicine, Division of Rheumatology, University of Washington, Seattke, Washington, USA.
Alfred Hj Kim *Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.ORCID 0000-0003-4074-0516
Jeffrey A Sparks *Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.ORCID 0000-0002-5556-4618
Beth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USUniversity of Washington · USWashington University in St. Louis · US

Funding

Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6M
NIAMS NIH HHS L30 AR072421NIAMS NIH HHS P30 AR073752
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsCOVID-19Rheumatic DiseasesArrhythmias, CardiacHumansHydroxychloroquineInflammationAntimalarialsHydroxychloroquinecardiovascular diseaseshydroxychloroquineinflammation

Identifiers

PMID32424027
OpenAlexW3025695287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.